Phase II Clinical Development of New Drugs
Ding-Geng Chen author Naitee Ting author Shuyen Ho author Joseph C Cappelleri author
Format:Paperback
Publisher:Springer Verlag, Singapore
Published:12th Dec '18
Currently unavailable, and unfortunately no date known when it will be back
This book focuses on how to appropriately plan and develop a Phase II program, and how to design Phase II clinical trials and analyze their data. It provides a comprehensive overview of the entire drug development process and highlights key questions that need to be addressed for the successful execution of Phase II, so as to increase its success in Phase III and for drug approval. Lastly it warns project team members of the common potential pitfalls and offers tips on how to avoid them.
“It provides a hands-on approach to each subject, and the necessary statistical background is presented in the most non-mathematical way possible. … Throughout the book, the scope of each subject is well defined, and if the reader has the need for further support, useful references are helpfully recommended. … I would strongly recommend this book to anyone working in clinical development or with an interest in this field, regardless of their background.” (David Manteigas, ISCB News, iscb.info, Issue 65, June, 2018)
ISBN: 9789811350740
Dimensions: unknown
Weight: 454g
241 pages
Softcover reprint of the original 1st ed. 2017